mannitol has been researched along with bortezomib in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 4 (80.00) | 24.3611 |
2020's | 1 (20.00) | 2.80 |
Authors | Studies |
---|---|
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Dai, Z; Liu, Y; Tu, Y; Wang, J; Zhu, L | 1 |
Deng, Y; Ding, J; Liu, M; Song, Y; Tang, X; Zhao, B | 1 |
Denora, N; Iacobazzi, RM; Lopalco, A; Stella, VJ | 1 |
1 review(s) available for mannitol and bortezomib
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
4 other study(ies) available for mannitol and bortezomib
Article | Year |
---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Folate-targeted pH-sensitive bortezomib conjugates for cancer treatment.
Topics: Bortezomib; Cell Line, Tumor; Cell Survival; Drug Carriers; Folic Acid; HeLa Cells; Humans; Hydrogen-Ion Concentration; Mannitol; Polyethylene Glycols | 2019 |
A Sialylated-Bortezomib Prodrug Strategy Based on a Highly Expressed Selectin Target for the Treatment of Leukemia or Solid Tumors.
Topics: Animals; Antineoplastic Agents; Apoptosis; Bortezomib; Cell Line, Tumor; Cell Membrane Permeability; Cell Proliferation; Cell Survival; Dose-Response Relationship, Drug; Humans; Leukemia; Male; Mannitol; Mice; Molecular Targeted Therapy; N-Acetylneuraminic Acid; Prodrugs; Selectins | 2019 |
Bortezomib Aqueous Solubility in the Presence and Absence of D-Mannitol: A Clarification With Formulation Implications.
Topics: Boronic Acids; Bortezomib; Mannitol; Solubility; Water | 2021 |